Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Aurelius Health Group vs Curex

Aurelius Health Group
Graded #311

Lower grade

vs+8.400000000000006
Curex
Graded #130

Higher grade

The verdict

Curex takes it — 69.2/100 to 60.8/100.

Curex grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Curex (Curex, Inc.) offers compounded semaglutide ($149/mo) and tirzepatide ($199/mo) in injectable and oral dissolving tablet formats.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
54
54
Dose & formulationCurex +23
52
75
Clinical oversightCurex +8
76
84
Labs & monitoringAurelius Health Group +8
63
55
FulfillmentCurex +29
61
90
Contract termsEven
61
61
Aurelius Health Group · left barCurex · right bar

The numbers

MetricAurelius Health GroupCurex
WeighScore60.8/10069.2/100
GradeCC
Scorecard rank#311#130
SemaglutideNot disclosed$199/mo (compounded oral)
Tirzepatide$199/mo (microdose tier, compounded)$199/mo (compounded oral)
CoverageCoverage not published45 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Aurelius Health Group

Graded #311 · C

Strengths

  • Pricing fully published and bundled: $89 first month, then $199/mo all-in — more transparent than most compounded brands
  • LegitScript Certified
  • Care-inclusive model: consults, monthly monitoring, and secure messaging rather than Rx-only
  • Unusually candid about the limited evidence base for microdosing

Where it loses points

  • The advertised $89 is a first-month new-patient rate; every month after it is $199
  • This is a 1 mg microdose programme and nothing else — no labelled therapeutic dose is sold, so it is not an alternative to a full-dose prescription
  • No state count is published, only 'most US states', confirmed at intake
  • The site's own comparison table calls 2.4 mg/week the tirzepatide 'standard full dose'; 2.4 mg is the semaglutide maintenance dose, and tirzepatide is labelled 2.5-15 mg/week
  • Compounded tirzepatide is not an FDA-approved finished product
Curex

Graded #130 · C

Strengths

  • LegitScript certified
  • Named entity (Curex, Inc.) with two offices — Miami FL and NYC
  • No membership fee ever
  • Injectable and oral dissolving tablet formats
  • Third-party lab testing via FDA/DEA certified labs

Where it loses points

  • Not available in AK, AR, CT, HI, MA, NM, MO
  • Compounded only — explicitly states 'We don't prescribe Ozempic, Wegovy, Zepbound, or Mounjaro'
  • Primary business is allergy immunotherapy — GLP-1 is a newer vertical

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard